mdlinx mdlinx

Rheumatology - Other Arthritis News & Articles

What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content

  • Our medical editors bring you the best key learnings published in the top peer-reviewed rheumatology medical journals. You'll find overviews here ranked and organized by topic on rheumatoid arthritis, joint and back pain, osteoarthritis, lupus and autoimmune diseases, osteoporosis and bone fractures. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
  • MDLinx exclusive content includes monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, as well as clinical pearls from The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (2) Full Text Articles (9) Focus on Osteoarthritis
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides Annals of Rheumatic Diseases, May 21, 2013    Clinical Article

2 The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis Annals of Rheumatic Diseases, May 21, 2013    Review Article

Prior Articles

3 Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment Rheumatology, May 20, 2013    Review Article

4 Pseudoarthrosis in atypical femoral fracture: case report Osteoporosis International, May 20, 2013

5 Chinese Herbal Formula Huo-Luo-Xiao-Ling Dan Protects against Bone Damage in Adjuvant Arthritis by Modulating the Mediators of Bone Remodeling Full Text Evidence-based Complementary and Alternative Medicine , May 17, 2013    Clinical Article

6 Can we reduce the dosage of biologics in spondyloarthritis? Autoimmunity Reviews, May 16, 2013    Review Article

7 Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis Cytokine, May 16, 2013    Clinical Article

8 Patient reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: Findings through 2 years of the GO-REVEAL trial Arthritis Care & Research , May 13, 2013    Clinical Article

9 Lysophosphatidic acid receptor LPA1 is essential for development of arthritis Arthritis & Rheumatism, May 13, 2013    Clinical Article

10 Location of CD4+ T Cell Priming Regulates the Differentiation of Th1 and Th17 Cells and Their Contribution to Arthritis The Journal of Immunology, May 13, 2013    Review Article

11 Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis Annals of Rheumatic Diseases, May 9, 2013    Clinical Article

12 Engineered Regulatory T Cells Coexpressing MHC Class II:Peptide Complexes Are Efficient Inhibitors of Autoimmune T Cell Function and Prevent the Development of Autoimmune Arthritis The Journal of Immunology, May 9, 2013    Clinical Article

13 Self-Reported Arthritis Burden and Management in South Carolina Southern Medical Journal, May 8, 2013    Clinical Article

14 From inhibition of radiographic progression to maintaining structural integrity: a methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials Annals of Rheumatic Diseases, May 8, 2013    Clinical Article

15 Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009 Pharmacoepidemiology and Drug Safety, May 8, 2013    Clinical Article

16 Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis Clinical and Experimental Rheumatology Online, May 6, 2013    Clinical Article

17 Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis The Journal of Rheumatology, May 6, 2013    Clinical Article

18 Improving diagnosis of early inflammatory arthritis : results of a novel triage system Clinical and Experimental Rheumatology Online, May 3, 2013    Clinical Article

19 Ultrasound-integrated tight control in early psoriatic arthritis during adalimumab treatment Clinical and Experimental Rheumatology Online, May 3, 2013    Clinical Article

20 Vaccination and Inflammatory Arthritis: Overview of Current Vaccines and Recommended Uses in Rheumatology Current Rheumatology Reports, May 2, 2013    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Rheumatology

Highlights in Rheumatology

ACPA correlate with disease progression in JIA

In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.

Read the article summary

Predicting cardiovascular mortality in SLE

In a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.

Read the article summary

Anti-apoA-1 antibodies predict cardiovascular disease in RA patients

In a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Rheumatology Articles

Last month's top read Top Articles of 2012

1 Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study Annals of Rheumatic Diseases, April 11, 2013

2 A prospective randomized comparison of neoprene vs thermoplast hand-based thumb spica splinting for trapeziometacarpal arthrosis Osteoarthritis and Cartilage , April 3, 2013

3 Pain experiences and self-management strategies among middle-aged and older adults with arthritis Journal of Clinical Nursing, April 2, 2013

4 Pathogen-specific Risk of Reactive Arthritis from Bacterial Causes of Foodborne Illness The Journal of Rheumatology, April 5, 2013

5 Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis The Journal of Rheumatology, April 18, 2013    Evidence Based Medicine    Review Article

6 Psoriasis vulgaris and Psoriasis pustulosa Epidemiology, Quality of Life, Comorbidities and Treatment Current Rheumatology Reviews, April 19, 2013

7 Hypertrophic Osteoarthropathy: What a Rheumatologist Should Know About this Uncommon Condition Rheumatic Disease Clinics of North America, April 22, 2013    Review Article

8 The Influence of Evidence in the Surgical Treatment of Thumb Basilar Joint Arthritis Plastic and Reconstructive Surgery, April 4, 2013

9 New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast Drug Design, Development and Therapy, April 1, 2013    Free full text

10 Autonomic dysfunction in psoriatic arthritis Clinical Rheumatology, April 10, 2013
Exclusive Author Commentary

11 Schistosoma mansoni infection: an immune complex disease presenting with polyarthritis Rheumatology International, April 29, 2013

12 Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis Journal of Clinical Pharmacy and Therapeutics, April 24, 2013

13 High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires Annals of Rheumatic Diseases, April 8, 2013

14 Profile of certolizumab and its potential in the treatment of psoriatic arthritis Drug Design, Development and Therapy, April 25, 2013    Free full text

15 The HLA-Cw*06 allele and -1149 G/T polymorphism of extrapituitary promoter of PRL gene as a possible common genetic predisposing factors to psoriasis vulgaris and psoriatic arthritis in Czech population Rheumatology International, April 3, 2013    Review Article

16 Lipid-Associated Rheumatologic Syndromes Rheumatic Disease Clinics of North America, April 23, 2013    Review Article

17 Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis Immunologic Research, April 26, 2013

18 Clinical-surgical treatment of temporomandibular joint disorder in a psoriatic arthritis patient Head & Face Medicine, April 15, 2013    Free full text

19 The diagnostic utility of matrix metalloproteinase-3 and high-sensitivity C-reactive protein for predicting rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-negative patients with recent-onset undifferentiated arthritis Rheumatology International, March 18, 2013

20 Patient-reported Health-related Quality of Life with Apremilast for Psoriatic Arthritis: A Phase II, Randomized, Controlled Study The Journal of Rheumatology, April 16, 2013

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close